Annovis Bio, Inc. Research And Development Expense

• Annovis Bio, Inc. showed an increase of +26.1% in Research And Development Expense from 2024 to 2025.
• This data is from Annovis Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
• XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2019 to 2025), Annovis Bio, Inc.'s Research And Development Expense has grown by 3,148.4%.
• Historical annual values: Fiscal year 2025: $25.22 million | Fiscal year 2024: $20.00 million | Fiscal year 2023: $38.79 million | Fiscal year 2022: $16.52 million | Fiscal year 2021: $8.48 million | Fiscal year 2020: $3.05 million | Fiscal year 2019: $776.3 thousand.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026